CN1032118C - 调节和改善生物生长生存状态的方法及设备 - Google Patents
调节和改善生物生长生存状态的方法及设备 Download PDFInfo
- Publication number
- CN1032118C CN1032118C CN 91109014 CN91109014A CN1032118C CN 1032118 C CN1032118 C CN 1032118C CN 91109014 CN91109014 CN 91109014 CN 91109014 A CN91109014 A CN 91109014A CN 1032118 C CN1032118 C CN 1032118C
- Authority
- CN
- China
- Prior art keywords
- oxide
- fluoride
- equipment
- treatment
- energy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract description 44
- 238000001228 spectrum Methods 0.000 claims abstract description 167
- 238000004088 simulation Methods 0.000 claims abstract description 98
- 150000001875 compounds Chemical class 0.000 claims abstract description 21
- 230000001105 regulatory effect Effects 0.000 claims abstract description 21
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 36
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 36
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 25
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 claims description 22
- IATRAKWUXMZMIY-UHFFFAOYSA-N strontium oxide Chemical compound [O-2].[Sr+2] IATRAKWUXMZMIY-UHFFFAOYSA-N 0.000 claims description 22
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 21
- 229910052814 silicon oxide Inorganic materials 0.000 claims description 20
- 239000011787 zinc oxide Substances 0.000 claims description 18
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 claims description 14
- 229910000423 chromium oxide Inorganic materials 0.000 claims description 14
- 239000004744 fabric Substances 0.000 claims description 14
- 229910000428 cobalt oxide Inorganic materials 0.000 claims description 13
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 claims description 13
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 13
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 claims description 12
- 239000005751 Copper oxide Substances 0.000 claims description 12
- 229910000431 copper oxide Inorganic materials 0.000 claims description 12
- YBMRDBCBODYGJE-UHFFFAOYSA-N germanium oxide Inorganic materials O=[Ge]=O YBMRDBCBODYGJE-UHFFFAOYSA-N 0.000 claims description 12
- 239000000395 magnesium oxide Substances 0.000 claims description 12
- PVADDRMAFCOOPC-UHFFFAOYSA-N oxogermanium Chemical compound [Ge]=O PVADDRMAFCOOPC-UHFFFAOYSA-N 0.000 claims description 12
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 claims description 12
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims description 11
- 229910000476 molybdenum oxide Inorganic materials 0.000 claims description 11
- PQQKPALAQIIWST-UHFFFAOYSA-N oxomolybdenum Chemical compound [Mo]=O PQQKPALAQIIWST-UHFFFAOYSA-N 0.000 claims description 11
- 229910052746 lanthanum Inorganic materials 0.000 claims description 10
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 claims description 10
- 241001132374 Asta Species 0.000 claims description 9
- 230000036760 body temperature Effects 0.000 claims description 9
- ORUIBWPALBXDOA-UHFFFAOYSA-L magnesium fluoride Chemical compound [F-].[F-].[Mg+2] ORUIBWPALBXDOA-UHFFFAOYSA-L 0.000 claims description 9
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 7
- -1 ferric flouride Chemical compound 0.000 claims description 7
- 239000010936 titanium Substances 0.000 claims description 7
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 6
- 239000011651 chromium Substances 0.000 claims description 6
- 239000010955 niobium Substances 0.000 claims description 6
- 150000004767 nitrides Chemical class 0.000 claims description 6
- 229910052719 titanium Inorganic materials 0.000 claims description 6
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 5
- 229910000420 cerium oxide Inorganic materials 0.000 claims description 5
- 229910052804 chromium Inorganic materials 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 239000010949 copper Substances 0.000 claims description 5
- 229910052732 germanium Inorganic materials 0.000 claims description 5
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 claims description 5
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 claims description 5
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 claims description 5
- 239000011669 selenium Substances 0.000 claims description 5
- 229910001928 zirconium oxide Inorganic materials 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- 229910052684 Cerium Inorganic materials 0.000 claims description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 4
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 4
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 4
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims description 4
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- 239000000292 calcium oxide Substances 0.000 claims description 4
- 239000010941 cobalt Substances 0.000 claims description 4
- 229910017052 cobalt Inorganic materials 0.000 claims description 4
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 4
- 229910052802 copper Inorganic materials 0.000 claims description 4
- 229910052744 lithium Inorganic materials 0.000 claims description 4
- 239000011777 magnesium Substances 0.000 claims description 4
- 229910052750 molybdenum Inorganic materials 0.000 claims description 4
- 239000011733 molybdenum Substances 0.000 claims description 4
- 229910000480 nickel oxide Inorganic materials 0.000 claims description 4
- 229910052758 niobium Inorganic materials 0.000 claims description 4
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- 229910052711 selenium Inorganic materials 0.000 claims description 4
- 229910052710 silicon Inorganic materials 0.000 claims description 4
- 239000010703 silicon Substances 0.000 claims description 4
- 229910052712 strontium Inorganic materials 0.000 claims description 4
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims description 4
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 4
- 229910052727 yttrium Inorganic materials 0.000 claims description 4
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- 229910052726 zirconium Inorganic materials 0.000 claims description 4
- FRWYFWZENXDZMU-UHFFFAOYSA-N 2-iodoquinoline Chemical compound C1=CC=CC2=NC(I)=CC=C21 FRWYFWZENXDZMU-UHFFFAOYSA-N 0.000 claims description 3
- ZSLUVFAKFWKJRC-IGMARMGPSA-N 232Th Chemical compound [232Th] ZSLUVFAKFWKJRC-IGMARMGPSA-N 0.000 claims description 3
- 229910052582 BN Inorganic materials 0.000 claims description 3
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- 229910052776 Thorium Inorganic materials 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- 229910052790 beryllium Inorganic materials 0.000 claims description 3
- LTPBRCUWZOMYOC-UHFFFAOYSA-N beryllium oxide Inorganic materials O=[Be] LTPBRCUWZOMYOC-UHFFFAOYSA-N 0.000 claims description 3
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims description 3
- 239000010931 gold Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 3
- 229910000484 niobium oxide Inorganic materials 0.000 claims description 3
- URLJKFSTXLNXLG-UHFFFAOYSA-N niobium(5+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Nb+5].[Nb+5] URLJKFSTXLNXLG-UHFFFAOYSA-N 0.000 claims description 3
- 229910052715 tantalum Inorganic materials 0.000 claims description 3
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 claims description 3
- ZCUFMDLYAMJYST-UHFFFAOYSA-N thorium dioxide Chemical compound O=[Th]=O ZCUFMDLYAMJYST-UHFFFAOYSA-N 0.000 claims description 3
- 229910003452 thorium oxide Inorganic materials 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 2
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 claims description 2
- 229910052796 boron Inorganic materials 0.000 claims description 2
- 229910052810 boron oxide Inorganic materials 0.000 claims description 2
- JKWMSGQKBLHBQQ-UHFFFAOYSA-N diboron trioxide Chemical compound O=BOB=O JKWMSGQKBLHBQQ-UHFFFAOYSA-N 0.000 claims description 2
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 229910052735 hafnium Inorganic materials 0.000 claims description 2
- 229910000449 hafnium oxide Inorganic materials 0.000 claims description 2
- WIHZLLGSGQNAGK-UHFFFAOYSA-N hafnium(4+);oxygen(2-) Chemical compound [O-2].[O-2].[Hf+4] WIHZLLGSGQNAGK-UHFFFAOYSA-N 0.000 claims description 2
- GNRSAWUEBMWBQH-UHFFFAOYSA-N oxonickel Chemical compound [Ni]=O GNRSAWUEBMWBQH-UHFFFAOYSA-N 0.000 claims description 2
- 229910010271 silicon carbide Inorganic materials 0.000 claims description 2
- MTPVUVINMAGMJL-UHFFFAOYSA-N trimethyl(1,1,2,2,2-pentafluoroethyl)silane Chemical compound C[Si](C)(C)C(F)(F)C(F)(F)F MTPVUVINMAGMJL-UHFFFAOYSA-N 0.000 claims description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 claims description 2
- 229910052721 tungsten Inorganic materials 0.000 claims description 2
- 239000010937 tungsten Substances 0.000 claims description 2
- 229910052788 barium Inorganic materials 0.000 claims 5
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims 5
- KLZUFWVZNOTSEM-UHFFFAOYSA-K Aluminium flouride Chemical compound F[Al](F)F KLZUFWVZNOTSEM-UHFFFAOYSA-K 0.000 claims 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims 2
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 claims 2
- PQXKHYXIUOZZFA-UHFFFAOYSA-M lithium fluoride Chemical compound [Li+].[F-] PQXKHYXIUOZZFA-UHFFFAOYSA-M 0.000 claims 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 claims 2
- BHHYHSUAOQUXJK-UHFFFAOYSA-L zinc fluoride Chemical compound F[Zn]F BHHYHSUAOQUXJK-UHFFFAOYSA-L 0.000 claims 2
- OFEAOSSMQHGXMM-UHFFFAOYSA-N 12007-10-2 Chemical compound [W].[W]=[B] OFEAOSSMQHGXMM-UHFFFAOYSA-N 0.000 claims 1
- 229910015900 BF3 Inorganic materials 0.000 claims 1
- 229910021582 Cobalt(II) fluoride Inorganic materials 0.000 claims 1
- 229910021594 Copper(II) fluoride Inorganic materials 0.000 claims 1
- ASDFNNABRKNTPE-UHFFFAOYSA-N N.[Th] Chemical compound N.[Th] ASDFNNABRKNTPE-UHFFFAOYSA-N 0.000 claims 1
- 229910052581 Si3N4 Inorganic materials 0.000 claims 1
- NRTOMJZYCJJWKI-UHFFFAOYSA-N Titanium nitride Chemical compound [Ti]#N NRTOMJZYCJJWKI-UHFFFAOYSA-N 0.000 claims 1
- 229910026551 ZrC Inorganic materials 0.000 claims 1
- LRTTZMZPZHBOPO-UHFFFAOYSA-N [B].[B].[Hf] Chemical compound [B].[B].[Hf] LRTTZMZPZHBOPO-UHFFFAOYSA-N 0.000 claims 1
- OTCHGXYCWNXDOA-UHFFFAOYSA-N [C].[Zr] Chemical compound [C].[Zr] OTCHGXYCWNXDOA-UHFFFAOYSA-N 0.000 claims 1
- SJKRCWUQJZIWQB-UHFFFAOYSA-N azane;chromium Chemical compound N.[Cr] SJKRCWUQJZIWQB-UHFFFAOYSA-N 0.000 claims 1
- CFJRGWXELQQLSA-UHFFFAOYSA-N azanylidyneniobium Chemical compound [Nb]#N CFJRGWXELQQLSA-UHFFFAOYSA-N 0.000 claims 1
- OYLGJCQECKOTOL-UHFFFAOYSA-L barium fluoride Chemical compound [F-].[F-].[Ba+2] OYLGJCQECKOTOL-UHFFFAOYSA-L 0.000 claims 1
- 229910001632 barium fluoride Inorganic materials 0.000 claims 1
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Inorganic materials [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 claims 1
- CSSYLTMKCUORDA-UHFFFAOYSA-N barium(2+);oxygen(2-) Chemical compound [O-2].[Ba+2] CSSYLTMKCUORDA-UHFFFAOYSA-N 0.000 claims 1
- UQVOJETYKFAIRZ-UHFFFAOYSA-N beryllium carbide Chemical compound [Be][C][Be] UQVOJETYKFAIRZ-UHFFFAOYSA-N 0.000 claims 1
- XTDAIYZKROTZLD-UHFFFAOYSA-N boranylidynetantalum Chemical compound [Ta]#B XTDAIYZKROTZLD-UHFFFAOYSA-N 0.000 claims 1
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 claims 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 claims 1
- 229910001634 calcium fluoride Inorganic materials 0.000 claims 1
- QCCDYNYSHILRDG-UHFFFAOYSA-K cerium(3+);trifluoride Chemical compound [F-].[F-].[F-].[Ce+3] QCCDYNYSHILRDG-UHFFFAOYSA-K 0.000 claims 1
- VIEXQFHKRAHTQS-UHFFFAOYSA-N chloroselanyl selenohypochlorite Chemical compound Cl[Se][Se]Cl VIEXQFHKRAHTQS-UHFFFAOYSA-N 0.000 claims 1
- UFGZSIPAQKLCGR-UHFFFAOYSA-N chromium carbide Chemical compound [Cr]#C[Cr]C#[Cr] UFGZSIPAQKLCGR-UHFFFAOYSA-N 0.000 claims 1
- YCYBZKSMUPTWEE-UHFFFAOYSA-L cobalt(ii) fluoride Chemical compound F[Co]F YCYBZKSMUPTWEE-UHFFFAOYSA-L 0.000 claims 1
- GWFAVIIMQDUCRA-UHFFFAOYSA-L copper(ii) fluoride Chemical compound [F-].[F-].[Cu+2] GWFAVIIMQDUCRA-UHFFFAOYSA-L 0.000 claims 1
- CTNMMTCXUUFYAP-UHFFFAOYSA-L difluoromanganese Chemical compound F[Mn]F CTNMMTCXUUFYAP-UHFFFAOYSA-L 0.000 claims 1
- YZUCHPMXUOSLOJ-UHFFFAOYSA-N ethyne;thorium Chemical compound [Th].[C-]#[C] YZUCHPMXUOSLOJ-UHFFFAOYSA-N 0.000 claims 1
- QHEDSQMUHIMDOL-UHFFFAOYSA-J hafnium(4+);tetrafluoride Chemical compound F[Hf](F)(F)F QHEDSQMUHIMDOL-UHFFFAOYSA-J 0.000 claims 1
- WHJFNYXPKGDKBB-UHFFFAOYSA-N hafnium;methane Chemical compound C.[Hf] WHJFNYXPKGDKBB-UHFFFAOYSA-N 0.000 claims 1
- FUJCRWPEOMXPAD-UHFFFAOYSA-N lithium oxide Chemical compound [Li+].[Li+].[O-2] FUJCRWPEOMXPAD-UHFFFAOYSA-N 0.000 claims 1
- 229910001947 lithium oxide Inorganic materials 0.000 claims 1
- UNASZPQZIFZUSI-UHFFFAOYSA-N methylidyneniobium Chemical compound [Nb]#C UNASZPQZIFZUSI-UHFFFAOYSA-N 0.000 claims 1
- LNDHQUDDOUZKQV-UHFFFAOYSA-J molybdenum tetrafluoride Chemical compound F[Mo](F)(F)F LNDHQUDDOUZKQV-UHFFFAOYSA-J 0.000 claims 1
- 229910052759 nickel Inorganic materials 0.000 claims 1
- DBJLJFTWODWSOF-UHFFFAOYSA-L nickel(ii) fluoride Chemical compound F[Ni]F DBJLJFTWODWSOF-UHFFFAOYSA-L 0.000 claims 1
- QGLKJKCYBOYXKC-UHFFFAOYSA-N nonaoxidotritungsten Chemical compound O=[W]1(=O)O[W](=O)(=O)O[W](=O)(=O)O1 QGLKJKCYBOYXKC-UHFFFAOYSA-N 0.000 claims 1
- BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 claims 1
- 239000011698 potassium fluoride Substances 0.000 claims 1
- 235000003270 potassium fluoride Nutrition 0.000 claims 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 claims 1
- 229910001950 potassium oxide Inorganic materials 0.000 claims 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 claims 1
- ABTOQLMXBSRXSM-UHFFFAOYSA-N silicon tetrafluoride Chemical compound F[Si](F)(F)F ABTOQLMXBSRXSM-UHFFFAOYSA-N 0.000 claims 1
- FVRNDBHWWSPNOM-UHFFFAOYSA-L strontium fluoride Chemical compound [F-].[F-].[Sr+2] FVRNDBHWWSPNOM-UHFFFAOYSA-L 0.000 claims 1
- 229910001637 strontium fluoride Inorganic materials 0.000 claims 1
- 229910001936 tantalum oxide Inorganic materials 0.000 claims 1
- MZQZQKZKTGRQCG-UHFFFAOYSA-J thorium tetrafluoride Chemical compound F[Th](F)(F)F MZQZQKZKTGRQCG-UHFFFAOYSA-J 0.000 claims 1
- XROWMBWRMNHXMF-UHFFFAOYSA-J titanium tetrafluoride Chemical compound [F-].[F-].[F-].[F-].[Ti+4] XROWMBWRMNHXMF-UHFFFAOYSA-J 0.000 claims 1
- 229910003470 tongbaite Inorganic materials 0.000 claims 1
- NXHILIPIEUBEPD-UHFFFAOYSA-H tungsten hexafluoride Chemical compound F[W](F)(F)(F)(F)F NXHILIPIEUBEPD-UHFFFAOYSA-H 0.000 claims 1
- 229910001930 tungsten oxide Inorganic materials 0.000 claims 1
- 229940105963 yttrium fluoride Drugs 0.000 claims 1
- RBORBHYCVONNJH-UHFFFAOYSA-K yttrium(iii) fluoride Chemical compound F[Y](F)F RBORBHYCVONNJH-UHFFFAOYSA-K 0.000 claims 1
- ZVWKZXLXHLZXLS-UHFFFAOYSA-N zirconium nitride Chemical compound [Zr]#N ZVWKZXLXHLZXLS-UHFFFAOYSA-N 0.000 claims 1
- OMQSJNWFFJOIMO-UHFFFAOYSA-J zirconium tetrafluoride Chemical compound F[Zr](F)(F)F OMQSJNWFFJOIMO-UHFFFAOYSA-J 0.000 claims 1
- 241000282414 Homo sapiens Species 0.000 abstract description 39
- 230000012010 growth Effects 0.000 abstract description 37
- 241001465754 Metazoa Species 0.000 abstract description 19
- 229910052729 chemical element Inorganic materials 0.000 abstract description 16
- 230000007704 transition Effects 0.000 abstract description 14
- 241000196324 Embryophyta Species 0.000 abstract description 13
- 230000004083 survival effect Effects 0.000 abstract description 7
- 244000005700 microbiome Species 0.000 abstract description 5
- 230000003213 activating effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 150
- 230000000694 effects Effects 0.000 description 67
- 201000010099 disease Diseases 0.000 description 34
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 34
- 230000005855 radiation Effects 0.000 description 31
- 239000000203 mixture Substances 0.000 description 28
- 230000003187 abdominal effect Effects 0.000 description 26
- 210000003128 head Anatomy 0.000 description 25
- 210000004027 cell Anatomy 0.000 description 24
- 239000000463 material Substances 0.000 description 21
- 210000001015 abdomen Anatomy 0.000 description 20
- 230000001225 therapeutic effect Effects 0.000 description 20
- 208000027418 Wounds and injury Diseases 0.000 description 19
- 239000000126 substance Substances 0.000 description 18
- 230000006870 function Effects 0.000 description 17
- 229910052751 metal Inorganic materials 0.000 description 17
- 239000000758 substrate Substances 0.000 description 17
- 230000036541 health Effects 0.000 description 16
- 108020004414 DNA Proteins 0.000 description 15
- 230000008859 change Effects 0.000 description 15
- 239000003814 drug Substances 0.000 description 15
- 230000001976 improved effect Effects 0.000 description 15
- 238000002560 therapeutic procedure Methods 0.000 description 15
- 208000002193 Pain Diseases 0.000 description 14
- 239000002184 metal Substances 0.000 description 14
- 230000036407 pain Effects 0.000 description 14
- 239000004033 plastic Substances 0.000 description 14
- 229920003023 plastic Polymers 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 14
- 206010052428 Wound Diseases 0.000 description 13
- 210000003734 kidney Anatomy 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 230000004071 biological effect Effects 0.000 description 12
- 210000001124 body fluid Anatomy 0.000 description 12
- 239000010839 body fluid Substances 0.000 description 12
- 230000003203 everyday effect Effects 0.000 description 12
- 238000010438 heat treatment Methods 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 230000004087 circulation Effects 0.000 description 11
- 210000002683 foot Anatomy 0.000 description 11
- 230000033001 locomotion Effects 0.000 description 11
- 210000005036 nerve Anatomy 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 11
- XHCLAFWTIXFWPH-UHFFFAOYSA-N [O-2].[O-2].[O-2].[O-2].[O-2].[V+5].[V+5] Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[V+5].[V+5] XHCLAFWTIXFWPH-UHFFFAOYSA-N 0.000 description 10
- 230000006378 damage Effects 0.000 description 10
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 229910001935 vanadium oxide Inorganic materials 0.000 description 10
- 206010061218 Inflammation Diseases 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 9
- 239000004568 cement Substances 0.000 description 9
- 230000035876 healing Effects 0.000 description 9
- 230000004054 inflammatory process Effects 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 210000002640 perineum Anatomy 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 8
- 210000000349 chromosome Anatomy 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 210000000653 nervous system Anatomy 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000012549 training Methods 0.000 description 8
- 208000030507 AIDS Diseases 0.000 description 7
- 208000006673 asthma Diseases 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 7
- 210000000481 breast Anatomy 0.000 description 7
- 206010015037 epilepsy Diseases 0.000 description 7
- 230000005284 excitation Effects 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- 208000014617 hemorrhoid Diseases 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 230000003595 spectral effect Effects 0.000 description 7
- 206010013935 Dysmenorrhoea Diseases 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 240000007594 Oryza sativa Species 0.000 description 6
- 235000007164 Oryza sativa Nutrition 0.000 description 6
- 210000000436 anus Anatomy 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000001684 chronic effect Effects 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 6
- 235000013601 eggs Nutrition 0.000 description 6
- 230000002440 hepatic effect Effects 0.000 description 6
- 208000006454 hepatitis Diseases 0.000 description 6
- 231100000283 hepatitis Toxicity 0.000 description 6
- 210000004698 lymphocyte Anatomy 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- 201000004384 Alopecia Diseases 0.000 description 5
- 208000005171 Dysmenorrhea Diseases 0.000 description 5
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 206010035664 Pneumonia Diseases 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 230000002490 cerebral effect Effects 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 230000005670 electromagnetic radiation Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 210000001508 eye Anatomy 0.000 description 5
- 230000012447 hatching Effects 0.000 description 5
- 206010022000 influenza Diseases 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 208000017169 kidney disease Diseases 0.000 description 5
- 210000002751 lymph Anatomy 0.000 description 5
- 239000000696 magnetic material Substances 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 210000003739 neck Anatomy 0.000 description 5
- 210000001331 nose Anatomy 0.000 description 5
- 210000004940 nucleus Anatomy 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 231100000915 pathological change Toxicity 0.000 description 5
- 230000036285 pathological change Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 235000009566 rice Nutrition 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- 206010008570 Chloasma Diseases 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 208000003351 Melanosis Diseases 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 208000018569 Respiratory Tract disease Diseases 0.000 description 4
- 238000001467 acupuncture Methods 0.000 description 4
- 231100000360 alopecia Toxicity 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000036770 blood supply Effects 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 206010006451 bronchitis Diseases 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000008034 disappearance Effects 0.000 description 4
- 230000005611 electricity Effects 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 210000001161 mammalian embryo Anatomy 0.000 description 4
- 239000011572 manganese Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 238000000554 physical therapy Methods 0.000 description 4
- 230000002685 pulmonary effect Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000005245 sintering Methods 0.000 description 4
- 230000003867 tiredness Effects 0.000 description 4
- 208000016255 tiredness Diseases 0.000 description 4
- 206010003445 Ascites Diseases 0.000 description 3
- 206010007134 Candida infections Diseases 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 208000007882 Gastritis Diseases 0.000 description 3
- 206010020880 Hypertrophy Diseases 0.000 description 3
- 208000007766 Kaposi sarcoma Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 208000005384 Pneumocystis Pneumonia Diseases 0.000 description 3
- 206010073755 Pneumocystis jirovecii pneumonia Diseases 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 238000005415 bioluminescence Methods 0.000 description 3
- 230000029918 bioluminescence Effects 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 208000019425 cirrhosis of liver Diseases 0.000 description 3
- 230000001143 conditioned effect Effects 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 230000001934 delay Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 230000003779 hair growth Effects 0.000 description 3
- 230000004217 heart function Effects 0.000 description 3
- 208000002672 hepatitis B Diseases 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 230000036512 infertility Effects 0.000 description 3
- 208000000509 infertility Diseases 0.000 description 3
- 231100000535 infertility Toxicity 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 3
- 210000000867 larynx Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 238000000053 physical method Methods 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 201000000317 pneumocystosis Diseases 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 210000000689 upper leg Anatomy 0.000 description 3
- 206010001497 Agitation Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 201000006474 Brain Ischemia Diseases 0.000 description 2
- 206010006458 Bronchitis chronic Diseases 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010014561 Emphysema Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 208000001034 Frostbite Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000005577 Gastroenteritis Diseases 0.000 description 2
- 206010018852 Haematoma Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000007514 Herpes zoster Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000004356 Hysteria Diseases 0.000 description 2
- 201000008197 Laryngitis Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 206010027374 Mental impairment Diseases 0.000 description 2
- 206010029164 Nephrotic syndrome Diseases 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 206010033078 Otitis media Diseases 0.000 description 2
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- 102000007562 Serum Albumin Human genes 0.000 description 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 2
- 206010047115 Vasculitis Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000001088 anti-asthma Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000002567 autonomic effect Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 201000003984 candidiasis Diseases 0.000 description 2
- 230000003727 cerebral blood flow Effects 0.000 description 2
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 208000007451 chronic bronchitis Diseases 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 208000012839 conversion disease Diseases 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000005283 ground state Effects 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 210000003016 hypothalamus Anatomy 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 2
- 208000028774 intestinal disease Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000001165 lymph node Anatomy 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 230000004379 myopia Effects 0.000 description 2
- 208000001491 myopia Diseases 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 208000035824 paresthesia Diseases 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 230000029553 photosynthesis Effects 0.000 description 2
- 238000010672 photosynthesis Methods 0.000 description 2
- 230000000191 radiation effect Effects 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 206010038464 renal hypertension Diseases 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 230000008010 sperm capacitation Effects 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000002889 sympathetic effect Effects 0.000 description 2
- UONOETXJSWQNOL-UHFFFAOYSA-N tungsten carbide Chemical compound [W+]#[C-] UONOETXJSWQNOL-UHFFFAOYSA-N 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 229910052720 vanadium Inorganic materials 0.000 description 2
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 1
- OTPDWCMLUKMQNO-UHFFFAOYSA-N 1,2,3,4-tetrahydropyrimidine Chemical compound C1NCC=CN1 OTPDWCMLUKMQNO-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010049153 Allergic sinusitis Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002153 Anal fissure Diseases 0.000 description 1
- 206010061628 Anal infection Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 208000016583 Anus disease Diseases 0.000 description 1
- 201000002909 Aspergillosis Diseases 0.000 description 1
- 208000036641 Aspergillus infections Diseases 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000009137 Behcet syndrome Diseases 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 206010005949 Bone cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010055000 Bromhidrosis Diseases 0.000 description 1
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 1
- 102100025588 Calcitonin gene-related peptide 1 Human genes 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007710 Cartilage injury Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010008528 Chillblains Diseases 0.000 description 1
- 108091060290 Chromatid Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010013886 Dysaesthesia Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 201000011275 Epicondylitis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010015218 Erythema multiforme Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000009531 Fissure in Ano Diseases 0.000 description 1
- 206010016936 Folliculitis Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 206010017062 Formication Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 201000000628 Gas Gangrene Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 241000288105 Grus Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010065952 Hyperpathia Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 208000008017 Hypohidrosis Diseases 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 208000019637 Infantile Diarrhea Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 208000008081 Intestinal Fistula Diseases 0.000 description 1
- 208000002260 Keloid Diseases 0.000 description 1
- 206010023330 Keloid scar Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 108090000913 Nitrate Reductases Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 240000007673 Origanum vulgare Species 0.000 description 1
- 235000010677 Origanum vulgare Nutrition 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 208000010886 Peripheral nerve injury Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000035755 Psychosomatic disease Diseases 0.000 description 1
- 208000020264 Puerperal Infection Diseases 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 201000004328 Pulpitis Diseases 0.000 description 1
- 206010037464 Pulpitis dental Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000019155 Radiation injury Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 206010039088 Rhinitis atrophic Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 208000016780 Scleredema Diseases 0.000 description 1
- 206010039705 Scleritis Diseases 0.000 description 1
- 206010055953 Scleroedema Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229910006404 SnO 2 Inorganic materials 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000016247 Soft tissue disease Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 208000004760 Tenosynovitis Diseases 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 102000002262 Thromboplastin Human genes 0.000 description 1
- 108010000499 Thromboplastin Proteins 0.000 description 1
- 229910010413 TiO 2 Inorganic materials 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 206010044684 Trismus Diseases 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- KYNKUCOQLYEJPH-UHFFFAOYSA-N [K][Ti] Chemical compound [K][Ti] KYNKUCOQLYEJPH-UHFFFAOYSA-N 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000004447 accommodation reflex Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 150000001257 actinium Chemical class 0.000 description 1
- 208000012826 adjustment disease Diseases 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 102000016679 alpha-Glucosidases Human genes 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 206010002512 anhidrosis Diseases 0.000 description 1
- 230000037001 anhydrosis Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 108010019077 beta-Amylase Proteins 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 108700004675 bleomycetin Proteins 0.000 description 1
- QYOAUOAXCQAEMW-UTXKDXHTSA-N bleomycin A5 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCCNCCCCN)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C QYOAUOAXCQAEMW-UTXKDXHTSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 208000024754 bloodshot eye Diseases 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- QYHKLBKLFBZGAI-UHFFFAOYSA-N boron magnesium Chemical compound [B].[Mg] QYHKLBKLFBZGAI-UHFFFAOYSA-N 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000005524 ceramic coating Methods 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 230000010002 chemokinesis Effects 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 210000004756 chromatid Anatomy 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 210000000613 ear canal Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 238000001827 electrotherapy Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003617 erythrocyte membrane Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 208000027685 extreme exhaustion Diseases 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000009123 feedback regulation Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000008175 fetal development Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 210000000630 fibrocyte Anatomy 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000010413 gardening Methods 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000024924 glomerular filtration Effects 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- VBJZVLUMGGDVMO-UHFFFAOYSA-N hafnium atom Chemical compound [Hf] VBJZVLUMGGDVMO-UHFFFAOYSA-N 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000002061 histotrophic effect Effects 0.000 description 1
- 230000000652 homosexual effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000001702 information therapy Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 230000037231 joint health Effects 0.000 description 1
- 210000001117 keloid Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 208000002741 leukoplakia Diseases 0.000 description 1
- 229960001614 levamisole Drugs 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 230000032630 lymph circulation Effects 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- SYHGEUNFJIGTRX-UHFFFAOYSA-N methylenedioxypyrovalerone Chemical compound C=1C=C2OCOC2=CC=1C(=O)C(CCC)N1CCCC1 SYHGEUNFJIGTRX-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 208000009928 nephrosis Diseases 0.000 description 1
- 231100001027 nephrosis Toxicity 0.000 description 1
- 230000008035 nerve activity Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- QELJHCBNGDEXLD-UHFFFAOYSA-N nickel zinc Chemical compound [Ni].[Zn] QELJHCBNGDEXLD-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 201000005111 ocular hyperemia Diseases 0.000 description 1
- 201000008557 oral mucosa leukoplakia Diseases 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000004783 oxidative metabolism Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000000803 paradoxical effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 206010035114 pityriasis rosea Diseases 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000004436 pseudomyopia Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 238000011555 rabbit model Methods 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 208000004124 rheumatic heart disease Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 208000007754 scleredema adultorum Diseases 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000011265 semifinished product Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000000323 shoulder joint Anatomy 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 201000005671 spondyloarthropathy Diseases 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000002463 transducing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 206010044652 trigeminal neuralgia Diseases 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 206010047470 viral myocarditis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 210000001260 vocal cord Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
- 229960002555 zidovudine Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0618—Psychological treatment
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Social Psychology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Child & Adolescent Psychology (AREA)
- Developmental Disabilities (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Radiation-Therapy Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cultivation Of Plants (AREA)
Abstract
Description
氧化物 | 碳化物 | 氮化物 | 氟化物 | 硼化物 | |
钴Co铜Cu钼Mo锂Li铍Be硼B镁Mg铝Al硅Si钾K钙Ca钛Ti钒V铬Cr锰Mn铁Fe镍Ni锌Zn锗Ge锶Sr锆Zr铌Nb | BeoB2O3MgOAl2O3SiO2KOCaOTiO2V2O5MnO2Fe2O3NiOZnOGeOSrOZrO2 | Be2CB4CNbcTiCVCCr3C2ZrcNbc | Be3N2BNNbNTiNVNCrNZrNNbN | MgF2MnF2ZrF2 | TiB2VB2CrB(Cr3B4)ZrB2NbB2 |
钽Ta铪Hf硒Se钍Tn钨W铈Ce金Au钇Y | HfO2TnO2CeO2Y2O3 | TaCHfCTnCWcW2C | TaNHfNTnN | TaB2HfBTnB4(TnB5)WB |
病名 | 治疗部位 | 每次治疗时间(分钟) | 每天治疗次数 | 治疗疗程(天) | 疗效评价 |
感冒伤风风疹肝炎痢疾急慢性支气管炎哮喘肺炎风湿热风湿性心脏病 | 面部、颈椎、脚底患处肝区、腹部、背部、脚底、脾脏腹部、脚底肺部、支气管、背部同上同上同上胸部、关节 | 20~6020~4020~6020~5020~6020~6020~6020~5020~50 | 1~41~41~31~41~21~31~31~21~2 | 1~61~1030~1501~103~3030~902~710~2010~60 | 早期疗效好,中晚期次之,≥50%止痒有效≥30%有效率≥80%有效率≥80%有效率≥60%有效率≥50%有效率≥80%缓解率≥40%缓解率≥40% |
高血压冠心病病毒性心肌炎雷诺氏症心律失常心力衰竭急慢性胃炎消化性溃疡慢性结肠炎肝硬化急慢性胰腺 | 胸部、颈椎、头部、脚底胸部、头、脚同上同上同上同上胃部、腹部″″肝、腹部、背部、脚患处、腹、腰部 | 20~4020~4020~4020~4020~4020~4020~40″″20~60″ | 1~21~21~21~21~21~21~2″″1~3″ | 303030305~305~305~3030″302~20 | 有效率≥50%有效率≥50%有效率≥50%有效率≥30%有效率≥50%有效率≥30%有效率≥85%≥80%≥80%≥50%≥50% |
胃肠神经官能症白血病糖尿病酸碱平衡紊乱肥胖营养不良脚气病肾病综合症尿毒症 | 胃、腹部、脚底全身、胸部、脾脏、腹部、脊椎、脚胰岛区、腹、腰、脚胸、腹、脊椎、脚腹部、背部、脚腹部、胃、肾区、脚患处肾区、脚、腹部、全身″ | 20~60″″″″″″″″ | 1~3″″″″″″″″ | 3~3030~90″5~30305~307~3030″ | 有效率≥70%≥30%≥30%≥50%缓解 ≥30%≥50%≥40%≥50%≥60% |
酒精中毒戒毒食物中毒放射病缓解增强麻醉镇静催眠镇痛止吐闭合性损伤开放性损伤手术伤口速愈烧伤 | 肝、腹、胃区、全身头、脚、腹、胃区、全身肝、腹、胃、全身全身注射麻醉药处头、脚、腹头、脚、胃、腹患处胃、腹患处患处″″ | 20~60″60605~2020~6020~5020~6020~4020~4020~40″″ | 1~311~31~211~211~31~31~21~3″″ | 5~3030/疗程1~73011~103012~102~103~5″ | 有效率≥50%≥30%≥70%≥50%≥70%≥80%≥70%≥80%≥80%≥85%≥90%≥90%″ |
冻伤毒蛇咬伤脓毒病疖痈蜂窝织炎淋巴管结炎丹毒腱鞘炎骨肿瘤周围神经损伤排尿困难尿潴瘤 | 患处″″″″″″″″″全身、患处、配合手术愈合患处会阴、腹部、肾区″ | 20~406030~50″″″″″″″20~6020~40″″ | 1~31~3″″″″″″″1~21~31~3″″ | 3~510″3~10″″″″2~8305~3010~305~20″ | 有效率≥90%≥80%≥80%≥85%≥85%″″″″≥50%缓解30%40%″ |
阴囊肿大膀胱炎前列腺炎肾性高血压胆、肾结石消炎、止痛不育、不孕症性功能障碍早产儿保健肝炎合并妊娠产褥感染外阴瘙痒女阴白斑 | 患处会阴、膀胱会阴、下腹肾区、腹、脚、头、全身患处全身、会阴、腹部、子宫、脚、脊椎全身、会阴全身全身、肝区、脚患处″″ | 20~40″″″″″″15~6020~4020~40″″ | 1~3″″″″″″1~31~21~3″″ | 5~30″″30~603~155~30″3~2020~805~15″30~60 | 有效率30%50%″″″″30%50%40%50%″缓解 |
子宫颈炎阴道炎盆腔炎功能性子宫出血泌乳闭经综合症经前期紧张症更年期综合症闭经痛经乳腺肿瘤气性坏疽乳腺炎乳腺小叶增生 | 患处″会阴会阴、子宫、投影区患处、脚、腹腹部、脚全身全身、腹部腹部患处、全身患处患处″ | 20~40″″″″″″″″30~604030~50″ | 1~3″″″″″″″″1~21~31~2″ | 305~3030″5~30″30″″30102~1030 | 有效率 ≥40%″″、缓解≥50%≥60%≥45%≥50%″缓解缓解≥70%≥40% |
疝腹膜炎肛、肠瘘、脓肿肛裂痔胆囊炎脉管炎下肢静脉曲张慢性小腿溃疡整形手术速愈器官移植排斥反应消除骨折速愈半月板软骨损伤 | 患处″″″″″″″″″″患处″ | 30~50″″″″″″″″20~4020~60″″ | 1~2″″″″″″″″1~21~3″″ | 30″″2~30″″″″″2~72~10″5~20 | 有效率≥30%≥50%″″″″≥30%缓解≥80%″≥80%≥50%≥50% |
断肢再植促愈化脓生骨髓炎类风湿关节炎关节炎骨质疏松症小儿麻痹后遗症颈、肩、腰痛肩关节周围炎肱骨外上髁炎新生儿呕吐新生儿硬肿症新生儿皮下坏疽败血症破伤风溶血病 | 患处″″″患处、全身″患处″″胃、腹部腹部、会阴部患处全身″″ | 20~60″″″″″″″″15~20″″″15~30″ | 1~3″″″″″″″″1~2″″″″″ | 3~1020~4030~60″″″3~30″″557″10″ | 有效率≥50%≥50%≥40%≥50%≥40%缓解≥50%″″≥80%≥70%≥60%≥30%≥30%缓解 |
婴儿腹泻小儿口腔炎小儿急性上呼吸道感染小儿肺炎小儿肾病小儿结核病小儿轻微脑功能失调遗尿免疫缺陷病瘫痪面神经炎三叉神经痛坐骨神经痛 | 腹部患处内或外侧胸肺部、需配合药物″肾区、脚、全身胸肺部、脾、脚头部、脚、脊椎会阴、腰肾区全身全身面部患处″ | 15~3015~2015~20″15~30″″″″6030~50″″ | 1~211″1~2″″″″″″″″ | 2~73~103~7″1020″3~2020303~15″″ | 有效率≥70%40%50%″50%50%30%60%缓解缓解50%30%″ |
癫痫脑损伤后遗症精神病、癔病、分裂症神经官能症神经衰弱癔病精神分裂症老年性痴呆单纯疱疹带状疱疹脓疱疮毛囊炎麻风 | 头部(脑)、脚、颈椎患处头部、全身头、脊椎、腹、脚″″″脑、全身患处″″″″用于控制溃疡、保护关节功能 | 30~50″″″″″″20~40″″″″30~60 | 1~2″″″″″″1~21~3″″″1~2 | 3~30″30″″″″305~10″″″30 | 有效率≥80%40%50%″″″45%30%80%″″″缓解 |
梅毒癣念珠菌病曲菌病疥疱过敏性皮炎、湿疹瘙痒病鸡眼软化光感性皮炎冻疮冻伤银屑病玫瑰糠疹多形红斑皮肤变应性结节性血管炎 | 患处″″″″″″″″″″″″″″ | 30~60″″″″″″″″″″″″″″ | 1~2″″″″″″″″″″″″″″ | 3010~30″″″″″″″2~7″10~30″″″ | 缓解有效率≥40%″50%″″40%″30%90%80%60%40%″″ |
白塞氏病红斑性狼疮硬皮病白癜风黄褐斑痤疮脂溢性皮炎脱发白发臭汗症无汗症疤痕疙瘩红眼症睑缘炎结膜炎 | 患处″″″″″″″配合药物″ ″腋下、全身腋下、脚底、全身患处双眼患处″ | 30~60″″″″″20~50″″″″20~4020~40″″ | 1~2″″″″″1~2″″″″1~31~2″″ | 3030″″″″30″″″″301~75~303~15 | 有效率≥40%缓解″″≥50%″50%″缓解″″″≥60%50%″ |
巩膜炎青光眼青少年近视老光眼鼻炎萎缩性、过敏性鼻窦炎咽炎、喉炎扁桃体炎中耳炎外耳道疖、炎牙痛、出血牙髓炎 | 患处″″″″″″″″″″″″ | 20~40″″″″″″″″″″″″ | 1~2″″″″″″″″″″″″ | 5~203030″″″″″″5~303~103~2030 | 有效率≥50%缓解≥40%缓解60%60%60%″″60%″60%45% |
口腔粘膜白斑病鹅口疮爱滋病肿瘤辐射防护延缓衰老人体保健消除疲劳恢复体能甲亢 | 患处″全身、胸、肝、腹、脾、淋巴、脚、头部患处、全身全身全身全身、头、脚、腹肾区、脚、腹、头部颈甲状腺处、腹、胃、肝、脚、全身 | 20~40″30~6030~6020~6020~4520~6020~5020~50 | 1~2″1~31~31~31~21~31~21~2 | 30″30301~3030305~2030 | 有效率≥45%″30%缓解50%50%60%60%30% |
Claims (13)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 91109014 CN1032118C (zh) | 1991-09-19 | 1991-09-19 | 调节和改善生物生长生存状态的方法及设备 |
EP19920402578 EP0533585B1 (en) | 1991-09-19 | 1992-09-18 | Apparatus for regulating and improving the status of development and survival of living organisms |
DE1992627814 DE69227814T2 (de) | 1991-09-19 | 1992-09-18 | Vorrichtung zur Regelung und Verbesserung des Entwicklungs- und Lebenserhaltungszustands lebender Organismen |
JP25134392A JPH06339537A (ja) | 1991-09-19 | 1992-09-21 | 生物の生長と生存状態を調節し改善する方法および装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 91109014 CN1032118C (zh) | 1991-09-19 | 1991-09-19 | 调节和改善生物生长生存状态的方法及设备 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1070580A CN1070580A (zh) | 1993-04-07 |
CN1032118C true CN1032118C (zh) | 1996-06-26 |
Family
ID=4909588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 91109014 Expired - Lifetime CN1032118C (zh) | 1991-09-19 | 1991-09-19 | 调节和改善生物生长生存状态的方法及设备 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0533585B1 (zh) |
JP (1) | JPH06339537A (zh) |
CN (1) | CN1032118C (zh) |
DE (1) | DE69227814T2 (zh) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0970205A (ja) * | 1995-09-05 | 1997-03-18 | Vergara Piccarga Alvaro | 種の生産性増加方法 |
GB9721506D0 (en) * | 1997-10-10 | 1997-12-10 | Virulite Limited | Treatment of diseases |
WO2001003492A2 (fr) * | 1999-07-13 | 2001-01-18 | Informatsionno-Volnovoi Tsentr 'big' Zakrytoe Aktsionernoe Obschestvo | Procede et dispositif pour agir sur des micro-organismes |
IL137366A0 (en) * | 2000-07-18 | 2001-07-24 | Shladot Metal Works Ltd | A method for increasing the fertilizing capability of sperm cells |
US6681136B2 (en) * | 2000-12-04 | 2004-01-20 | Science Medicus, Inc. | Device and method to modulate blood pressure by electrical waveforms |
GB0414113D0 (en) | 2004-06-24 | 2004-07-28 | Virulite Distrib Ltd | Cosmetic uses of electromagnetic radiation |
GB2416699B (en) * | 2004-08-05 | 2010-04-14 | Photo Therapeutics Ltd | Skin rejuvenation |
DE102005047517A1 (de) * | 2004-10-03 | 2006-06-14 | Stefan Bernhard | Vorrichtung zur Prävention und Behandlung von Mastitis mit Licht |
GB0512038D0 (en) | 2005-06-14 | 2005-07-20 | Dougal Gordon | Therapeutic and cosmetic uses of electromagnetic radiation |
CN100386018C (zh) * | 2005-08-31 | 2008-05-07 | 无锡市农业机械技术推广站 | 分体式植物谐振促生器 |
GB0812753D0 (en) | 2008-07-14 | 2008-08-20 | Dougal Gordon R P | Electromagnetic radiation and its therapeutic effect |
CN101828533B (zh) * | 2010-03-23 | 2011-11-09 | 江苏省农业科学院 | 移动式低剂量中子辐射刺激装置 |
JP2013022115A (ja) * | 2011-07-19 | 2013-02-04 | Takemoriko Hayashi | 健康・美容増進装置 |
CN103636416B (zh) * | 2013-12-02 | 2015-08-26 | 昆明理工大学 | MgCl2在促进植物硝态氮吸收中的应用 |
CN104782559A (zh) * | 2014-01-20 | 2015-07-22 | 中国农业科学院北京畜牧兽医研究所 | 一种用于评价肉鸡热舒适性的非侵入性内分泌指标及其应用 |
CN105148408A (zh) * | 2015-09-07 | 2015-12-16 | 北京周林频谱科技有限公司 | 一种便携式电子设备及其生物频谱发生层 |
CN105210696A (zh) * | 2015-11-03 | 2016-01-06 | 北京周林频谱科技有限公司 | 一种改善植物或农作物的发育、生长和生存的方法及装置 |
CN109748398A (zh) * | 2017-11-06 | 2019-05-14 | 重庆干城环保科技有限公司 | 一种表面纳米化量子生物能植入的生物载体的生产工艺及生物载体 |
CN110819031A (zh) * | 2019-10-29 | 2020-02-21 | 周林 | 一种温室大棚用频谱塑料薄膜及其生产工艺 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3100892A1 (de) * | 1981-01-14 | 1983-06-01 | Ludger 5471 Wassenach Mersmann | Beeinflussungsvorrichtung zur beeinflussung und regelung des zustandes, der wirkung, des verhaltens und/oder der reaktion von zu beeinflussenden objekten, wie z.b. biologische systeme, stoffe, pharmaka, terrestische bezirke, wasser, beton und/oder elektrotechnische geraete |
DE3300517A1 (de) * | 1982-01-09 | 1984-07-26 | Ludger 5445 Kottenheim Mersmann | Therapiegeraet als lasertherapiegeraet und/oder phototherapiegeraet und/oder als haematogenes lasertherapiegeraet und/oder als autooszillationstherapiegeraet und/oder als stromtherapiegeraet und/oder als magnetfeldtherapiegeraet und/oder als rauschtherapiegeraet und/oder als wahlweise kombination dieser verschiedenen therapiegeraete fuer den therapeutischen einsatz in der veterinaer- human- oder phytomedizin |
EP0164836A1 (en) * | 1984-04-06 | 1985-12-18 | BADGLEY, Laurence E. | Combination of vascular autonomic signal treatment and analyzing means |
CN1005896B (zh) * | 1985-09-20 | 1989-11-29 | 周林 | 频谱匹配治疗装置 |
CN1006759B (zh) * | 1987-05-20 | 1990-02-14 | 周林 | 人体频谱匹配效应场治疗装置及生产方法 |
-
1991
- 1991-09-19 CN CN 91109014 patent/CN1032118C/zh not_active Expired - Lifetime
-
1992
- 1992-09-18 EP EP19920402578 patent/EP0533585B1/en not_active Expired - Lifetime
- 1992-09-18 DE DE1992627814 patent/DE69227814T2/de not_active Expired - Lifetime
- 1992-09-21 JP JP25134392A patent/JPH06339537A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0533585B1 (en) | 1998-12-09 |
JPH06339537A (ja) | 1994-12-13 |
DE69227814D1 (de) | 1999-01-21 |
EP0533585A1 (en) | 1993-03-24 |
CN1070580A (zh) | 1993-04-07 |
DE69227814T2 (de) | 1999-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1032118C (zh) | 调节和改善生物生长生存状态的方法及设备 | |
US5814078A (en) | Method and apparatus for regulating and improving the status of development and survival of living organisms | |
CN1404835A (zh) | 修复和促进胃肠道粘膜组织再生的组合物及其制备方法 | |
Tang | Challenges and advances in stem cell therapy | |
Liu et al. | The effects of electromagnetic fields on human health: recent advances and future | |
CN1541628A (zh) | 高恒温高压氧床微波癌症热预防与热治疗设备 | |
CN110194657A (zh) | 一种具有治疗保健效果的太赫兹材料及其制备方法和应用 | |
CN102491810A (zh) | 一种蛹虫草培养基 | |
CN101057980A (zh) | 一种高疗效功能复合材料及其制备方法与用途 | |
CN1596092A (zh) | 全身温热疗法和装置 | |
CN102839206A (zh) | 一种促进人自体产生骨髓造血干细胞的制剂方法 | |
CN1660355A (zh) | 一种治疗跌打损伤、风湿骨痛的中药制剂及其制备方法 | |
CN1034020A (zh) | 改善了生物学价值之植物的制备和应用 | |
CN108823171A (zh) | 一种基因工程细胞及体外高效扩增nk细胞的方法 | |
CN1663602A (zh) | 一种治疗神经衰弱的药物 | |
CN1957946A (zh) | 一种慢性病康复芯片的制作方法和所制作康复芯片及用途 | |
CN1541627A (zh) | 微波高压氧脑血管疾病预防与治疗多用机 | |
CN106071584A (zh) | 以糙米为载体培育灵芝生物型饮品 | |
CN109593725A (zh) | 一种重组间充质干细胞及其应用 | |
CN1151685A (zh) | 改善衰老过程的方法和设备 | |
CN106750705A (zh) | 用量子光波复合材料制备量子光波理疗材料的方法 | |
CN102485888A (zh) | 脉冲电磁场促进人脐带间充质干细胞体外成骨分化作用 | |
CN1312104A (zh) | 治疗骨伤的系列药物 | |
CN105999416A (zh) | 用于整形充填的自体脂肪与脐带间充质干细胞组合物 | |
CN1188516C (zh) | 一种重组纳豆激酶的编码核苷酸序列及该酶的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C15 | Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993) | ||
OR01 | Other related matters | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Zhou Lin Document name: Notice on the extension of the term of patent right |
|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Zhou Lin Document name: Special business review memo |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 19930407 Assignee: ZHOULIN BIO-SPECTRUM TECHNOLOGY CO.,LTD. Assignor: Zhou Lin Contract record no.: 2010110000032 Denomination of invention: Method and equipment for adjusting and improving growing state of living things Granted publication date: 19960626 License type: Exclusive License Record date: 20100316 |
|
C17 | Cessation of patent right | ||
CX01 | Expiry of patent term |
Expiration termination date: 20110919 Granted publication date: 19960626 |
|
DD01 | Delivery of document by public notice |
Addressee: Zhou Lin Document name: Notification of Expiration of Patent Right Duration |